ArticleContemporary clinical trials communications2019

The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials.

Matthew Michelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.